Keyword: blockbuster drugs


Celgene Offers $7.2 Billion for Receptos

17.07.2015 - US biotech firm Celgene has agreed to pay $7.2 billion, or $232 per share, to acquire compatriot Receptos, a biotech company that makes a potential blockbuster drug to treat...

Strategy & Management

Discovering the Future of Pharma

30.09.2014 - Dramatic changes to the scientific and business environments have made it impossible for pharmaceutical companies to continue operating as they have in the past. A perceived...

Plant Construction & Process Technology

ChemOutsourcing: An Annual Cult Classic

29.05.2013 - When Billy Joel once sang about spending his weekend on the Jersey Shore, he most likely wasn't thinking about the pharma, chemical and biotech industries' best and brightest...